These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16000329)

  • 1. Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation.
    Feterowski C; Novotny A; Kaiser-Moore S; Mühlradt PF; Rossmann-Bloeck T; Rump M; Holzmann B; Weighardt H
    Int Immunol; 2005 Aug; 17(8):1035-46. PubMed ID: 16000329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection.
    Weighardt H; Kaiser-Moore S; Vabulas RM; Kirschning CJ; Wagner H; Holzmann B
    J Immunol; 2002 Sep; 169(6):2823-7. PubMed ID: 12218091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
    Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
    J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance.
    Liu J; Buckley JM; Redmond HP; Wang JH
    J Immunol; 2010 May; 184(10):5802-8. PubMed ID: 20400705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
    Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
    Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.
    Johnson AC; Heinzel FP; Diaconu E; Sun Y; Hise AG; Golenbock D; Lass JH; Pearlman E
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):589-95. PubMed ID: 15671286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-activating lipopeptide-2 exerts protective effects in a murine sepsis model.
    Zeckey C; Tschernig T; Hildebrand F; Frink M; Frömke C; Dorsch M; Krettek C; Barkhausen T
    Shock; 2010 Jun; 33(6):614-9. PubMed ID: 19940812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CC chemokine receptor 2 regulates leukocyte recruitment and IL-10 production during acute polymicrobial sepsis.
    Feterowski C; Mack M; Weighardt H; Bartsch B; Kaiser-Moore S; Holzmann B
    Eur J Immunol; 2004 Dec; 34(12):3664-73. PubMed ID: 15517610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis.
    Leendertse M; Willems RJ; Giebelen IA; van den Pangaart PS; Wiersinga WJ; de Vos AF; Florquin S; Bonten MJ; van der Poll T
    J Immunol; 2008 Apr; 180(7):4865-74. PubMed ID: 18354210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved host defense against septic peritonitis in mice lacking MyD88 and TRIF is linked to a normal interferon response.
    Reim D; Rossmann-Bloeck T; Jusek G; Prazeres da Costa O; Holzmann B
    J Leukoc Biol; 2011 Sep; 90(3):613-20. PubMed ID: 21628330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.
    Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF
    Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens.
    Raby AC; Holst B; Le Bouder E; Diaz C; Ferran E; Conraux L; Guillemot JC; Coles B; Kift-Morgan A; Colmont CS; Szakmany T; Ferrara P; Hall JE; Topley N; Labéta MO
    Sci Transl Med; 2013 May; 5(185):185ra64. PubMed ID: 23677593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
    Downer EJ; Johnston DG; Lynch MA
    Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
    Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
    Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of pulmonary immune responses by the TLR2/6 agonist MALP-2 and effect on melanoma metastasis to the lung.
    Schill T; Schön MP; Pletz N; Emmert S; Schön M
    Exp Dermatol; 2012 Feb; 21(2):91-8. PubMed ID: 22044500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
    Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
    Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of TLR2 expression by inflammatory stimuli is required for endothelial cell responses to lipopeptides.
    Satta N; Kruithof EK; Reber G; de Moerloose P
    Mol Immunol; 2008 Nov; 46(1):145-57. PubMed ID: 18722665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.